Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
CPI203 could be dosed to the mice by oral administration at 5 mg/kg twice per day for 7 days
LY 2109761
related to this research
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
also known as Ceftaroline fosamil and PPI 0903
CK-1827452 - CAS# 873697-71-3 228 CPI203 could be dosed toCK 1827452, CAS No. 873697 71 3, is a cardiac specific myosin activator. It is clinically tested for its role in the treatment of left ventricular systolic heart failure. CK 1827452 specifically targets and activates myocardial ATPase and improves energy utilization. CK 1827452 improves systolic function by increasing the systolic ejection duration stroke volume, without consuming more ATP energy, oxygen or altering intracellular calcium levels